Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP13 | P45452 | 4/20 | 0.43 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.43 |
| ▸ | MMP3 | P08254 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 14/20 | 0.41 |
| ▸ | RPS6KA1 | Q15418 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.37 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.37 |
| ▸ | CACNA1I | Q9P0X4 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10163490 | 0.94 | MMP13 (0.42) | MMP13ADAMTS4MMP3MAPK1RPS6KA1 | |
| SCHEMBL8226284 | 0.92 | MMP13 (0.47) | MMP13ADAMTS4MMP3MAPK1RPS6KA1 | |
| SCHEMBL8225501 | 0.91 | MMP13 (0.48) | MMP13ADAMTS4MMP3MAPTCACNA1G | |
| SCHEMBL8225565 | 0.91 | TP53 (0.43) | MMP13ADAMTS4MMP3MAPT | |
| SCHEMBL10163453 | 0.90 | L3MBTL1 (0.45) | MMP13ADAMTS4MMP3 | |
| SCHEMBL10163488 | 0.90 | MMP13 (0.44) | MMP13ADAMTS4MMP3MAPT | |
| SCHEMBL10163506 | 0.90 | MMP13 (0.45) | MMP13ADAMTS4MMP3MAPK1RPS6KA1 | |
| SCHEMBL10163512 | 0.90 | MMP13 (0.43) | MMP13ADAMTS4MMP3MAPK1RPS6KA1 | |
| SCHEMBL8226605 | 0.90 | MMP13 (0.43) | MMP13ADAMTS4MMP3MAPK1RPS6KA1 | |
| SCHEMBL8226281 | 0.90 | MMP13 (0.42) | MMP13ADAMTS4MMP3MAPK1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007139856-A2 | HETEROBICYCLIC METALLOPROTEASE INHIBITORS | ALANTOS PHARMACEUTICALS, INC. (US) | 2007-12-06 | — | — | WO | disclosed |